Chronix Biomedical Competitors and Similar CompaniesClear all
GRAIL's competitors and similar companies include Elypta and OncoLens.
 Elypta Elypta is a company that develops a liquid biopsy platform intended to prevent cancer mortality through earlier detection. |  OncoLens OncoLens (also known as Lynkcare) is a company that develops an AI-based oncology care platform. | ||
Founding Date | Founding Date 2016 | Founding Date 2017 | Founding Date 2016 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Menlo Park, US HQ London, GB Durham, US Washington, US | Locations Solna, SE HQ | Locations Atlanta, US HQ |
Employees | Employees 9109% decrease | Employees 29 | Employees 287% decrease |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 6.8m (over 6 years ago) | Latest funding round $ 2.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 2b | Total funding raised $ 11.3m | Total funding raised $ 7.2m |
For sources of this data, please see the company profile
View Company Profiles
Elypta
HQ
Solna, SE
Employees
29
Elypta is a company that develops a liquid biopsy platform intended to prevent cancer mortality through earlier detection.
View companyOncoLens
HQ
Atlanta, US
Employees
28↓ 7% decrease
OncoLens (also known as Lynkcare) is a company that develops an AI-based oncology care platform.
View company